Insider filing · MNPR
Arthur J Klausner
Director
profile →
Monopar Therapeutics Inc.
MNPR · Healthcare · 11 filings in 24 months
ticker →
Arthur J Klausner sold $312K of Monopar Therapeutics (MNPR)
Executed Dec 18 2025, disclosed Dec 19 2025, 1 day later.
Value, as filed
$312K
4,660 sh × $67.06
Executed
Dec 18 2025
the trade date, as filed
Disclosed
Dec 19 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AKArthur J Klausner (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Monopar Therapeutics Inc. (MNPR). The largest single filing was $312K of MNPR (4,660 sh × $67.06, as filed), executed Dec 18 2025.
The name
MNPRHealthcare · Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→